WallStSmart

ExlService Holdings Inc (EXLS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ExlService Holdings Inc generates 706% more annual revenue ($2.09B vs $258.90M). EXLS leads profitability with a 12.0% profit margin vs -15.5%. EXLS earns a higher WallStSmart Score of 63/100 (C+).

EXLS

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 7.5Value: 8.0Quality: 7.8
Piotroski: 6/9Altman Z: 4.26

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EXLSUndervalued (+70.8%)

Margin of Safety

+70.8%

Fair Value

$103.45

Current Price

$31.88

$71.57 discount

UndervaluedFair: $103.45Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EXLS3 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.2610/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
27.3%9/10

Every $100 of equity generates 27 in profit

PEG RatioValuation
1.008/10

Growing faster than its price suggests

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

EXLS0 concerns · Avg: 0/10

No major concerns identified

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : EXLS

The strongest argument for EXLS centers on Altman Z-Score, Return on Equity, PEG Ratio. Revenue growth of 12.7% demonstrates continued momentum. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : EXLS

No major red flags identified for EXLS, but monitor valuation.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

EXLS profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

EXLS scores higher overall (63/100 vs 41/100) and 12.7% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ExlService Holdings Inc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

ExlService Holdings, Inc. provides operations management and analysis services in the United States, the United Kingdom, and internationally. The company is headquartered in New York, New York.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?